IQVIA HOLDINGS INC.
For the period ended Dec 31, 2025. Filed Feb 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 17, 2026
IQV$278.84+2.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Exhibit Index
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Exhibit Number | Exhibit Description | Filed Herewith | Form | File No. | Exhibit | Filing Date |
| 3.1 | Amended and Restated Certificate of Incorporation of IQVIA Holdings Inc., effective April 24, 2025. | 8-K | 001-35907 | 3.1 | April 24, 2025 | |
| 3.2 | Amended and Restated Bylaws of IQVIA Holdings Inc., effective April 18, 2023. | 8-K | 001-35907 | 3.2 | April 18, 2023 | |
| 4.1 | Description of the Company's Securities. | X | ||||
| 4.2 | Indenture, dated as of September 28, 2016, among Quintiles IMS Incorporated, the Guarantors listed therein and U.S. Bank National Association, as Trustee. | 8-K | 001-35907 | 4.1 | October 3, 2016 | |
| 4.3 | Indenture, dated May 10, 2019, among IQVIA Inc., as Issuer, U.S. Bank National Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors. | 8-K | 001-35907 | 4.1 | May 10, 2019 | |
| 4.4 | Indenture, dated August 13, 2019, among IQVIA Inc., as Issuer, U.S. Bank National Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors. | 8-K | 001-35907 | 4.1 | August 13, 2019 | |
| 4.5 | Indenture, dated June 24, 2020, among IQVIA Inc., as Issuer, U.S. Bank National Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors. | 8-K | 001-35907 | 4.1 | June 24, 2020 | |
| 4.6 | Indenture, dated March 3, 2021, among IQVIA Inc., as Issuer, U.S. Bank National Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors. | 8-K | 001-35907 | 4.1 | March 3, 2021 | |
| 4.7 | Indenture, dated May 23, 2023, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as Trustee of the 6.500% Senior Notes due 2030 and certain subsidiaries of the Issuer as guarantors. | 8-K | 001-35907 | 4.2 | May 23, 2023 | |
| 4.8 | Amended and Restated Indenture, dated December 19, 2023, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as trustee of the 5.700% Senior Secured Notes due 2028 and the Company and certain subsidiaries of the Issuer as guarantors. | S-4 | 001-35907 | 4.8 | January 5, 2024 | |
| 4.9 | Supplemental Indenture, dated as of June 27, 2024, among the subsidiary guarantors named on the signature pages thereto and U.S. Bank Trust Company, National Association, as trustee of the 5.700% Senior Secured Notes due 2028. | 10-Q | 001-35907 | 4.1 | July 22, 2024 | |
| 4.10 | Supplemental Indenture, dated as of December 5, 2025, among the subsidiary guarantors named on the signature pages thereto and U.S. Bank Trust Company, National Association, as trustee of the 5.700% Senior Secured Notes due 2028. | X | ||||
| 4.11 | Amended and Restated Indenture, dated December 19, 2023, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as trustee of the 6.250% Senior Secured Notes due 2029 and the Company and certain subsidiaries of the Issuer as guarantors. | S-4 | 001-35907 | 4.9 | January 5, 2024 | |
| 4.12 | Supplemental Indenture, dated as of June 27, 2024, among the subsidiary guarantors named on the signature pages thereto and U.S. Bank Trust Company, National Association, as trustee of the 6.250% Senior Secured Notes due 2029. | 10-Q | 001-35907 | 4.2 | July 22, 2024 | |
| 4.13 | Supplemental Indenture, dated as of December 5, 2025, among the subsidiary guarantors named on the signature pages thereto and U.S. Bank Trust Company, National Association, as trustee of the 6.250% Senior Secured Notes due 2029. | X | ||||
| 4.14 | Indenture, dated June 4, 2025, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as trustee of the 6.250% Senior Notes due 2032 and certain subsidiaries of the Issuer as guarantors. | 8-K | 001-35907 | 4.1 | June 4, 2025 | |
| 10.1 | Fifth Amended and Restated Credit Agreement, dated as of August 25, 2021, by and among IQVIA Inc., IQVIA RDS Inc., IQVIA AG, IQVIA Solutions Japan K.K., IQVIA Holdings Inc., the Guarantors party thereto and the Lenders party thereto (Annex A to Exhibit 10.1 filed August 25, 2021). | 8-K | 001-35907 | 10.1 | August 25, 2021 | |
| 10.2 | Amendment No. 1 to Fifth Amended and Restated Credit Agreement, dated June 16, 2022, among IQVIA Inc., IQVIA Holdings Inc., IQVIA RDS Inc. the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders party thereto. | 8-K | 001-35907 | 10.1 | June 16, 2022 | |
| 10.3 | Amendment No. 2 to Fifth Amended and Restated Credit Agreement, dated April 17, 2023, among IQVIA Inc., IQVIA Holdings Inc., IQVIA RDS Inc., IQVIA AG, IQVIA Japan K.K., the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders party thereto. | 8-K | 001-35907 | 10.1 | April 18, 2023 | |
| 10.4 | Amendment No. 3 to Fifth Amended and Restated Credit Agreement, dated November 28, 2023, among IQVIA Inc., IQVIA Holdings Inc., IQVIA RDS Inc., IQVIA AG, IQVIA Solutions Japan LLC, the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders party thereto. | 8-K | 001-35907 | 10.1 | November 23, 2023 | |
| 10.5 | Amendment No. 4 to Fifth Amended and Restated Credit Agreement, dated March 10, 2025, among IQVIA Inc., IQVIA Holdings Inc., IQVIA RDS Inc., the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders party thereto. | 8-K | 001-35907 | 10.1 | March 10, 2025 | |
| 10.6 | Amendment No. 5 to Fifth Amended and Restated Credit Agreement, dated December 9, 2025, among IQVIA Inc., IQVIA Holdings Inc., IQVIA RDS Inc., IQVIA AG, IQVIA Solutions Japan LLC, the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders party thereto. | 8-K | 001-35907 | 10.1 | December 9, 2025 | |
| 10.7 | Amended and Restated Pledge and Security Agreement, dated as of March 17, 2014, among Healthcare Technology Intermediate Holdings, Inc., IMS Health Incorporated, each of the grantors party thereto, and Bank of America, N.A., as Administrative Agent. | IMSHealth S-1/A | 333-193159 | 10.33 | March 24, 2014 | |
| 10.8 | U.S. Guaranty, dated as of March 17, 2014, among Healthcare Technology Intermediate Holdings, Inc., as Holdings, IMS Health Incorporated, as Parent Borrower, the other Guarantors party thereto from time to time, and Bank of America, N.A., as Administrative Agent. | IMSHealth S-1/A | 333-193159 | 10.34 | March 24, 2014 | |
| 10.9† | Form of Director Indemnification Agreement | X | ||||
| 10.10† | Form of Confidentiality and Restrictive Covenants Agreement. | 10-K | 001-35907 | 10.9 | February 15, 2024 | |
| 10.11† | Work Product Assignment Agreement. | 10-K | 001-35907 | 10.10 | February 15, 2024 | |
| 10.12† | Quintiles Transnational Holdings Inc. 2013 Stock Incentive Plan. | S-1/A | 333-186708 | 10.22 | April 19, 2013 | |
| 10.13† | Form of Award Agreement Awarding Stock Appreciation Rights under the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan effective February 2017. | 10-K | 001-35907 | 10.41 | February 16, 2017 | |
| 10.14† | Quintiles IMS Holdings, Inc. Defined Contribution Executive Retirement Plan. | 8-K | 001-35907 | 10.7 | October 3, 2016 | |
| 10.15† | IMS Health Incorporated Defined Contribution Executive Retirement Plan, as amended and restated. | IMS Health S-1 | 333-193159 | 10.10 | January 2, 2014 | |
| 10.16† | First Amendment to the IMS Health Incorporated Retirement Excess Plan, dated March 17, 2009. | IMS Health S-1 | 333-193159 | 10.12 | January 2, 2014 | |
| 10.17† | Second Amendment to the IMS Health Incorporated Retirement Excess Plan, dated December 8, 2009. | IMS Health S-1 | 333-193159 | 10.13 | January 2, 2014 | |
| 10.18† | Third Amendment to the IMS Health Incorporated Retirement Excess Plan, dated April 5, 2011. | IMS Health S-1 | 333-193159 | 10.14 | January 2, 2014 | |
| 10.19† | Fourth Amendment to the IMS Health Incorporated Retirement Excess Plan (effective May 3, 2016). | IMS Health 10-Q | 001-36381 | 10.3 | July 28, 2016 | |
| 10.20† | IMS Health Incorporated Retirement Plan, as amended and restated effective January 1, 2020. | 10-K | 001-35907 | 10.19 | February 15, 2024 | |
| 10.21† | Quintiles IMS Holdings, Inc. 2014 Incentive and Stock Award Plan. | 8-K | 001-35907 | 10.6 | October 3, 2016 | |
| 10.22† | Form of IMS Stock Appreciation Rights Agreement under the 2014 Incentive and Stock Award Plan. | IMS Health 8-K | 001-36381 | 10.1 | February 10, 2015 | |
| 10.23† | IQVIA Holdings Inc. 2017 Incentive Stock Award Plan (f/k/a Quintiles IMS Holdings, Inc. 2017 Incentive and Stock Award Plan). | DEF 14A | 001-35907 | Appendix B | February 22, 2017 | |
| 10.24† | Form of Award Agreement Awarding Stock Appreciation Rights under the Quintiles IMS Holdings, Inc. 2017 Incentive and Stock Award Plan effective April 2017. | 10-Q | 001-35907 | 10.8 | May 8, 2017 | |
| 10.25† | Form of Award Agreement Awarding Performance Shares under the Quintiles IMS Holdings, Inc. 2017 Incentive and Stock Award Plan effective April 2017. | 10-Q | 001-35907 | 10.9 | May 8, 2017 | |
| 10.26† | Form of Award Agreement Awarding Restricted Stock Units under the Quintiles IMS Holdings, Inc. 2017 Incentive and Stock Award Plan effective April 2017. | 10-Q | 001-35907 | 10.10 | May 8, 2017 | |
| 10.27† | IQVIA Inc. Employee Protection Plan and Summary Plan Description, as amended and restated effective July 1, 2023. | 10-Q | 001-35907 | 10.1 | August 1, 2023 | |
| 10.28† | IQVIA Savings Equalization Plan, effective January 1, 2018. | 10-K | 001-35907 | 10.27 | February 15, 2024 | |
| 10.29† | IQVIA Elective Deferred Compensation Plan, as amended and restated. | 10-K | 001-35907 | 10.28 | February 15, 2024 | |
| 10.30† | IQVIA Holdings Inc. Non-Employee Director Deferral Plan, effective January 1, 2017 (amended November 9, 2023). | 10-K | 001-35907 | 10.29 | February 15, 2024 | |
| 10.31† | Amended and Restated Employment Agreement between IQVIA Holdings Inc. and Ari Bousbib, dated February 18, 2019. | 10-K | 001-35907 | 10.60 | February 19, 2019 | |
| 10.32† | Stock Appreciation Rights Agreement between IMS Health Holdings, Inc. and Ari Bousbib, dated February 10, 2015. | IMS Health 10-K | 001-36381 | 10.34 | February 19, 2016 | |
| 10.33† | Amendment No. 1, dated December 31, 2015, to Stock Appreciation Rights Agreement between IMS Health Holdings, Inc. and Ari Bousbib dated February 10, 2015. | IMS Health 10-K | 001-36381 | 10.35 | February 19, 2016 | |
| 10.34† | Letter Agreement between the Company and Eric Sherbet, effective on March 1, 2018. | 10-K | 001-35907 | 10.72 | February 19, 2019 | |
| 10.35† | Letter Agreement between the Company and Ronald Bruehlman, effective on August 1, 2020. | 10-Q | 001-35907 | 10.1 | October 22, 2020 | |
| 10.36† | Letter Agreement between the Company and W. Richard Staub, effective on September 25, 2023. | 10-K | 001-35907 | 10.35 | February 15, 2024 | |
| 10.37† | Employment Agreement between IQVIA AG and Bhavik Patel, effective as of August 7, 2018, as amended on August 9, 2022 and August 1, 2023. | 10-K | 001-35907 | 10.36 | February 13, 2025 | |
| 10.38† | Employment Agreement between IMS Health Limited and Alistair Grenfell, effective as of July 15, 2003, as amended January 13, 2026. | X | ||||
| 19.1 | Securities Trading Policy | X | ||||
| 21.1 | List of Subsidiaries of IQVIA Holdings Inc. | X | ||||
| 22.1 | List of Subsidiary Guarantors and Affiliates who Collateralize the Company’s Securities. | X | ||||
| 23.1 | Consent of PricewaterhouseCoopers LLP. | X | ||||
| 31.1 | Certification of Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 31.2 · Certification of Executive Vice President and Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. · X | ||||||
|---|---|---|---|---|---|---|
| 32.1 · Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. · X | ||||||
| 32.2 · Certification of Executive Vice President and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. · X | ||||||
| 97.1† | Restatement Recovery Policy, dated November 9, 2023. | 10-K | 001-35907 | 97.1 | February 15, 2024 | |
| 101 | Interactive Data Files Pursuant to Rule 405 of Regulation S-T: (i) Consolidated Statements of Income, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Cash Flows, (v) Notes to Consolidated Financial Statements and (vi) Notes to Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | X | ||||
| 104 | Cover Page Interactive Data File. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | X | ||||
† Indicates management contract or compensatory plan or arrangement.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.